Abstract
OL-010 Sequential use of nitazoxanide (NTZ) as a salvage therapy in patient with recurrent mild to moderate Clostridium difficile infection (CDI): a prospective, open-label, randomized clinical trial
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have